Medasense Biometrics Ltd. of Ramat Gan at MEDICA 2017 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

Medasense Biometrics Ltd.

15, Hahilazon Street, 5252279 Ramat Gan
Israel
Telephone +972 73 7690321
Fax +972 3 5183878
mira@medasense.com

This company is co-exhibitor of
Israel Export & International Cooperation Institute

Hall map

MEDICA 2017 hall map (Hall 16): stand G28

Fairground map

MEDICA 2017 fairground map: Hall 16

Contact

Mira Altmark-Sofer

VP Business Development & Marketing

Israel

Phone
+972-50-5911212

Email
mira@medasense.com

Jochen Hoelscher

Clinical Director

Germany

Phone
+49 172 88 0 9595

Email
jochen@medasense.com

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.04  Intense medicine / anesthesiology / respiration
  • 01.04.04  Patient monitoring systems / Measuring stations
  • 01  Electromedical equipment / Medical Technology
  • 01.04  Intense medicine / anesthesiology / respiration
  • 01.04.04  Patient monitoring systems / Measuring stations
  • 01.04.04.07  Operation monitoring equipment

Our products

Product category: Operation monitoring equipment, Patient monitoring systems / Measuring stations

NEW! NOL™ (Nociception Level) Technology - Objective pain monitoring for optimizing analgesia

Medasense’s breakthrough NOL™ (Nociception Level) Technology, is the only pain assessment index based on dozens of pain-related physiological parameters and clinically validated as superior to other nociception/pain indicators. The patented platform technology is based on artificial intelligence algorithms and signal processing.
It enables objective, non-invasive, and continuous assessment and monitoring of the physiological response to pain.

More Less

Product category: Patient monitoring systems / Measuring stations, Operation monitoring equipment

PMD-200™: an intraoperative pain monitoring system

Medasense's flagship product is PMD-200™: an intraoperative pain monitoring system.
Based on the patented NOL™ technology, the PMD-200 provides objective, non-invasive, and continuous monitoring of the physiological response to pain.

The need: During general anesthesia, a patients’ body reacts to painful stimuli – although it is not consciously recognized. This intraoperative pain can stress the patient’s body and worsen pain after surgery. As the patient cannot communicate it is hard for clinicians to evaluate.
Consequently, the patient may be given insufficient analgesia, which can promote postoperative pain, or excessive analgesia which can result in overdosing and related complications.

The solution: By using the PMD-200™ in operating rooms, for patients under general anesthesia, clinicians are able to assess nociception, and titrate analgesic medications – avoiding excessive use or underuse that may result in significant complications.

PMD-200™ is a simple to use, stand-alone monitor.

More Less

About us

Company details

Medasense meets the clinical need to objectively assess pain.
Pain affects quality of life for millions of patients. Unmanaged pain delays recovery, increases morbidity and mortality, and overburdens healthcare resources.
There are currently no clinically accepted tools to objectively assess pain.  Clinicians must rely on patients’ subjective assessments, or simply guess when patients can’t communicate.

Medasense’s breakthrough NOL™ (Nociception Level) Technology, is the only pain assessment index based on dozens of pain-related physiological parameters and clinically validated as superior to other nociception/pain indicators. The patented platform technology is based on artificial intelligence algorithms and signal processing.
It enables objective, non-invasive, and continuous assessment and monitoring of the physiological response to pain.

More Less